Provided by Tiger Trade Technology Pte. Ltd.

Neurocrine Biosciences

156.76
+2.731.77%
Post-market: 156.760.00000.00%19:30 EDT
Volume:878.44K
Turnover:137.13M
Market Cap:15.99B
PE:22.98
High:157.03
Open:154.31
Low:153.70
Close:154.03
52wk High:186.12
52wk Low:122.14
Shares:102.00M
Float Shares:100.00M
Volume Ratio:0.81
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):6.82
EPS(LYR):4.67
ROE:22.09%
ROA:11.70%
PB:4.33
PE(LYR):33.57

Loading ...

May 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 06, 2026

Major Issues Report

Form 8-K - Current report
Feb 11, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2026

Major Issues Report

Form 8-K - Current report
Jan 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 24, 2025

Major Issues Report

Form 8-K - Current report
Nov 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]